表紙:眼科用ドラッグデリバリーの世界市場予測(2028年まで): COVID-19の影響と市場分析(技術・製剤タイプ・疾患タイプ・エンドユーザー・地域別)
市場調査レポート
商品コード
1032989

眼科用ドラッグデリバリーの世界市場予測(2028年まで): COVID-19の影響と市場分析(技術・製剤タイプ・疾患タイプ・エンドユーザー・地域別)

Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Formulation Type, Disease Type, and End User and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 171 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
眼科用ドラッグデリバリーの世界市場予測(2028年まで): COVID-19の影響と市場分析(技術・製剤タイプ・疾患タイプ・エンドユーザー・地域別)
出版日: 2021年09月30日
発行: The Insight Partners
ページ情報: 英文 171 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の眼科用ドラッグデリバリーの市場規模は、2021年に164億432万米ドルとなり、2021年から2028年にかけて7.4%のCAGRで拡大し、2028年には270億1,620万米ドルに達すると予測されています。

当レポートは世界の眼科用ドラッグデリバリー市場について調査しており、市場機会や動向、成長および抑制要因、技術・製剤タイプ・疾患タイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 世界の眼科用ドラッグデリバリー市場-重要なポイント

第3章 調査手法

第4章 眼科用ドラッグデリバリー市場-市場情勢

  • 概要
  • 専門家の見解

第5章 眼科用ドラッグデリバリー市場-主要な市場力学

  • 市場の成長要因
  • 市場の抑制要因
  • 市場機会
  • 今後の動向
  • 影響分析

第6章 眼科用ドラッグデリバリー市場-世界市場分析

  • 世界の眼科用ドラッグデリバリー市場の収益予測と分析
  • 地域別世界の眼科用ドラッグデリバリー市場-予測と分析
  • 主要企業の市場ポジショニング

第7章 眼科用ドラッグデリバリー市場分析-技術別

  • 概要
  • 技術別世界の眼科用ドラッグデリバリー市場シェア(%)、2021年および2028年
  • 埋め込み型眼科用ドラッグデリバリーシステム
  • 粒子状ドラッグデリバリーシステム
  • ナノ粒子ドラッグデリバリーシステム
  • その他

第8章 眼科用ドラッグデリバリー市場分析-製剤タイプ別

  • 概要
  • リポソームおよびナノ粒子市場
  • 溶液
  • 乳剤
  • 懸濁液
  • 軟膏

第9章 眼科用ドラッグデリバリー市場分析-疾患タイプ別

  • 概要
  • 疾患タイプ別の世界の眼科用ドラッグデリバリー市場シェア(%)、2021年および2028年
  • 白内障
  • ドライアイ症候群
  • 黄斑変性症
  • 緑内障
  • 糖尿病性網膜症
  • 糖尿病性黄斑浮腫
  • その他

第10章 眼科用ドラッグデリバリー市場分析-エンドユーザー別

  • 概要
  • エンドユーザー別の眼科用ドラッグデリバリー市場シェア(%)、2021年および2028年
  • 病院
  • 眼科クリニック
  • 外来手術センター

第11章 世界の眼科用ドラッグデリバリー市場-地域分析

  • 北米:眼科用ドラッグデリバリー市場
  • 欧州:眼科用ドラッグデリバリー市場の収益と2028年までの予測
  • アジア太平洋地域:眼科用ドラッグデリバリー市場
  • 中東・アフリカ:眼科用ドラッグデリバリー市場
  • 中南米:眼科用ドラッグデリバリー市場

第12章 COVID-19パンデミックが眼科用ドラッグデリバリー市場に与える影響

  • 北米:COVID-19パンデミックの影響評価
  • 欧州:COVID-19パンデミックの影響評価
  • アジア太平洋地域:COVID-19パンデミックの影響評価
  • 中東・アフリカ:COVID-19パンデミックの影響評価
  • 中南米:COVID-19パンデミックの影響評価

第13章 業界情勢

  • 概要
  • 市場参入企業による成長戦略、(%)
  • 有機的発展
  • 無機的開発

第14章 企業プロファイル

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Taiwan Liposome Company, Ltd.
  • Ocular Therapeutix, Inc.
  • GRAYBUG VISION, INC.
  • Alimera Sciences, Inc.
  • Envisia Therapeutics
  • Novartis AG
  • EYEGATE PHARMACEUTICALS, INC
  • Clearside Biomedical, Inc

第15章 付録

  • The Insight Partners について
  • 用語集
図表

LIST OF TABLES

  • Table 1. North America Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 2. North America Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 3. North America Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 4. North America Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 5. US Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 6. US Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 7. US Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 8. US Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 9. Canada Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)
  • Table 10. Canada Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Canada Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 12. Canada Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Mexico Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)
  • Table 14. Mexico Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Mexico Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 16. Mexico Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn).
  • Table 18. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn).
  • Table 19. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn).
  • Table 20. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
  • Table 21. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Mn)
  • Table 22. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn).
  • Table 23. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn).
  • Table 24. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Mn)
  • Table 25. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Mn)
  • Table 26. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn).
  • Table 27. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn).
  • Table 28. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Mn)
  • Table 29. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
  • Table 30. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
  • Table 31. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
  • Table 32. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
  • Table 33. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
  • Table 34. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
  • Table 35. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
  • Table 36. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
  • Table 37. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
  • Table 38. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
  • Table 39. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
  • Table 40. Spain Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 by End User (USD Million)
  • Table 41. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
  • Table 42. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
  • Table 43. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
  • Table 44. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
  • Table 45. Asia Pacific: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 46. Asia Pacific Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 47. Asia Pacific Ocular Drug Delivery Market, by Disease Type- Revenue and Forecast to 2028 (USD Million)
  • Table 48. Asia Pacific Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 49. China: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 50. China: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 51. China: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 52. China: Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 53. Japan: Ocular Drug Delivery Market, By Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 54. Japan: Ocular Drug Delivery Market, By Formulation Type- Revenue and Forecast to 2028 (USD Million)
  • Table 55. Japan: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 56. Japan: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 57. India: Ocular Drug Delivery Market, By Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 58. India: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 59. India: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 60. India: Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 61. Australia: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 62. Australia: Ocular Drug Delivery Market, By Formulation Type- Revenue and Forecast to 2028 (USD Million)
  • Table 63. Australia: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 64. Australia: Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 65. South Korea: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 66. South Korea: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 67. South Korea: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 68. South Korea: Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 69. Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 70. Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 71. Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type- Revenue and Forecast to 2028 (USD Million)
  • Table 72. Rest of Asia Pacific: Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 73. Middle East and Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Middle East and Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Middle East and Africa: Ocular Drug Delivery Market, by End Users - Revenue and Forecast to 2028 (US$ Million
  • Table 77. Saudi Arabia: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Saudi Arabia: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Saudi Arabia: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. UAE: Ocular Drug Delivery Market , by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. UAE: Ocular Drug Delivery Market , by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. UAE: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. UAE: Ocular Drug Delivery Market , by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. South Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 86. South Africa: Ocular Drug Delivery Market , by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. South Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. South Africa: Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 89. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 91. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 93. South and Central America Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 94. South and Central America Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 95. South and Central America Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 96. South and Central America Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 97. Brazil Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 98. Brazil Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 99. Brazil Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 100. Brazil Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 101. Argentina Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 102. Argentina Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 103. Argentina Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 104. Argentina Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 105. Rest of South and Central America Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 106. Rest of South and Central America Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
  • Table 107. Rest of South and Central America Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 108. Rest of South and Central America Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 109. Organic Developments Done By Companies
  • Table 110. Inorganic Developments Done by Companies
  • Table 111. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

  • Figure 1. Ocular Drug Delivery Market Segmentation
  • Figure 2. Ocular Drug Delivery Market Segmentation, By Region
  • Figure 3. Global Ocular Drug Delivery Market Overview
  • Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Ocular Drug Delivery Market, by Geography (US$ Million)
  • Figure 7. Global Ocular Drug Delivery Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Ocular Drug Delivery Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia pacific PEST Analysis
  • Figure 12. Middle East and Africa PEST Analysis
  • Figure 13. South and Central America PEST Analysis
  • Figure 14. Ocular Drug Delivery Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Ocular Drug Delivery Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Global Ocular Drug Delivery Market - By Geography Forecast and Analysis - 2021- 2028
  • Figure 17. Market Positioning of Key Players in Global Ocular Drug Delivery Market
  • Figure 18. Global Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)
  • Figure 19. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 21. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 22. Others Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. Global Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)
  • Figure 24. Global Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. Global Solution Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 26. Global Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 27. Global Suspension Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 28. Global Ointment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 29. Global Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)
  • Figure 30. Cataract Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 31. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 33. Glaucoma Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 34. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Others Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. Medical devices market Share, by End User, 2021 and 2028 (%)
  • Figure 38. Hospitals: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Ophthalmic Clinics: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 40. Ambulatory Surgical Centers: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 41. North America: Ocular Drug Delivery Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 42. North America Ocular Drug Delivery Market Revenue and Forecast to 2028 (USD Million)
  • Figure 43. North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
  • Figure 44. US: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 45. Canada: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 46. Mexico: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 47. Europe: Ocular Drug Delivery Market Revenue Overview, by Country, 2021 (US$ MN)
  • Figure 48. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 49. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 50. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 51. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 52. France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 53. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 54. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 55. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 56. Asia Pacific: Ocular Drug Delivery Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 57. Asia Pacific Ocular Drug Delivery Market Revenue and Forecast to 2028 (USD Million)
  • Figure 58. Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
  • Figure 59. China: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 60. Japan: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 61. India: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 62. Australia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 63. South Korea: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 64. Rest of Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 65. Middle East and Africa: Ocular Drug Delivery Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 66. Middle East & Africa Ocular Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
  • Figure 68. Saudi Arabia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. UAE: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. South Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Rest of Middle East and Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. South and Central America: Ocular Drug Delivery Market, By Key Country - Revenue (2021) (USD Million)
  • Figure 73. South and Central America: Ocular Drug Delivery Market- Revenue and Forecasts To 2028 (USD Million)
  • Figure 74. South and Central America: Ocular Drug Delivery Market Share by Country - 2021 & 2028, (%)
  • Figure 75. Brazil: Ocular Drug Delivery Market- Revenue and Forecasts To 2028 (USD Million)
  • Figure 76. Argentina: Ocular Drug Delivery Market- Revenue and Forecasts To 2028 (USD Million)
  • Figure 77. Rest of South and Central America: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 78. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 80. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 81. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 82. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
  • Figure 83. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00004206

The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.

The growth of the ocular drug delivery market is attributed to factors such as growing prevalence of eye disorders and rising research on ocular drug delivery. However, the market is likely to get impacted by several disadvantages associated with ocular drug delivery. For instance, ocular drug delivery system with eye drops led to extensive loss of the drug due to rapid elimination from the eye. Similarly, topical delivery of ocular drugs is unable to reach the posterior segment of the eye.

An ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended to instill, administer, or deliver drug/medicine to the eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue. Ocular drug formulations are primarily liquid forms, such as solutions, suspensions, and emulsions for treating anterior eye segment diseases. These formulations can be available in the form of advanced drug delivery systems like in-situ gel, microemulsion, nanoparticle, liposome, iontophoresis, nanosuspension, and ocular inserts.

The leading cause of blindness or low vision across the globe is cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and unaddressed refractive error. The majority of the global population have or had some eye disorder in their lifetime. As per the World Health Organization (WHO) report "Blindness and vision impairment" published in February 2021, around 2.2 billion people worldwide have a near or distance vision impairment. It has also estimated that the leading cause of vision loss or low vision is cataract (94 million) and uncorrected refractive errors (88.4 million). Further, the other common causes of vision loss are glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million).

According to the National Eye Institute (NEI), in the US, the number of people with cataracts is expected to double from 24.4 million in 2010 to about 50 million in 2050. Similarly, as per the Factsheet Glaucoma: Facts & Figures 2019, over 3 million people in the US were living with glaucoma. Moreover, as per the Canadian Survey on Disabilities 2017, 1.5 million Canadians had a sight loss, and around 5.59 million had an eye disease which could further lead to sight loss.

Additionally, as per the Royal National Institute of Blind People in 2017, in the UK, there were around 350,000 people registered as blind and partially sighted; about 173,735 were registered for severely sight impaired; and 176,125 were registered for sight-impaired.

The COVID-19 pandemic has become the most significant challenge across the world. As this pandemic has stressed healthcare systems across the globe, prioritizing the limited resources was essential to minimize hospital admissions. However, despite increased demand for ocular therapeutics such as eye drops, ointment, and suspension, there was a shortage of these products as new consumers entered the market. Manufacturers are also experiencing raised prices and potential shortages of raw ingredients due to supply restrictions. However, as the restrictions have been lifted and businesses are resuming, the demand-supply variables are coming back to normal. This will offer several growth prospects for ocular drug delivery therapeutics.

Based on technology, the ocular drug delivery market is segmented into implantable ocular drug delivery systems, particulate drug delivery systems, nano-particle drug delivery system, and others. The implantable ocular drug delivery systems segment would account for the largest market share in 2021, and the same segment is anticipated to register the highest CAGR during the forecast period.

Based on formulation type, the ocular drug delivery market is segmented into liposomes and nanoparticles, solution, emulsion, suspension, and ointment. The solution segment would hold the largest share of the market in 2021, and it is estimated to register the highest CAGR in the market during 2021-2028. The growth of the solution segment is attributed to the increasing adoption of ocular drug delivery systems in solution forms, like eye drops and injectables.

Based on disease type, the ocular drug delivery market is segmented into glaucoma, diabetic retinopathy, dry eye syndrome, macular degeneration, cataract, diabetic macular edema, and others. The cataract segment would account for the largest market share in 2021. The market for this segment is estimated to grow at the highest CAGR from 2021 to 2028.

Based on end user, the ocular drug delivery market is segmented into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment would hold the largest share of the market in 2021, while the ophthalmic clinics segment is estimated to register the highest CAGR in the market during the forecast period.

National Eye Institute, Royal National Institute of Blind People, American Academy of Ophthalmology, National Health Service, the Food and Drug Administration, the World Health Organization, and the Centers for Disease Control and Prevention of various countries are among the major primary and secondary sources referred to while preparing this report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Ocular drug delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction

  • 1.1. Scope of the Study
  • 1.2. The Insight Partners Research Report Guidance
  • 1.3. Market Segmentation
    • 1.3.1. Global Ocular Drug Delivery Market - By Technology
    • 1.3.2. Global Ocular Drug Delivery Market - By Formulation Type
    • 1.3.3. Global Ocular Drug Delivery Market - By Disease Type
    • 1.3.4. Global Ocular Drug Delivery Market - By End User
    • 1.3.5. Global Ocular Drug Delivery Market - By Geography

2. Global Ocular Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1. Coverage
  • 3.2. Secondary Research
  • 3.3. Primary Research

4. Ocular Drug Delivery Market - Market Landscape

  • 4.1. Overview
    • 4.1.1. North America - PEST Analysis
    • 4.1.2. Europe- PEST Analysis
    • 4.1.3. Asia Pacific- PEST Analysis
    • 4.1.4. Middle East And Africa- PEST Analysis
    • 4.1.5. South and Central America - PEST Analysis
  • 4.2. Expert Opinions

5. Ocular Drug Delivery Market- Key Market Dynamics

  • 5.1. Market Drivers
    • 5.1.1. Growing Prevalence of Eye Disorders
    • 5.1.2. Rising Research on Ocular Drug Delivery
  • 5.2. Market Restraints
    • 5.2.1. Disadvantages Associated with Ocular Drug Delivery
  • 5.3. Market Opportunities
    • 5.3.1. Increasing Awareness About Vision Care
  • 5.4. Future Trends
    • 5.4.1. Development of Innovative Products
  • 5.5. Impact analysis

6. Ocular Drug Delivery Market - Global Analysis

  • 6.1. Global Ocular Drug Delivery Market Revenue Forecast and Analysis
  • 6.2. Global Ocular Drug Delivery Market, By Geography - Forecast and Analysis
  • 6.3. Market Positioning of Key Players

7. Ocular Drug Delivery Market Analysis - By Technology

  • 7.1. Overview
  • 7.2. Global Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)
  • 7.3. Implantable Ocular Drug Delivery Systems
    • 7.3.1. Overview
    • 7.3.2. Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4. Particulate Drug Delivery Systems
    • 7.4.1. Overview
    • 7.4.2. Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5. Nano-Particle Drug Delivery System
    • 7.5.1. Overview
    • 7.5.2. Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6. Others
    • 7.6.1. Overview
    • 7.6.2. Others Market Revenue and Forecast to 2028 (US$ Mn)

8. Ocular Drug Delivery Market Analysis - By Formulation Type

  • 8.1. Overview
    • 8.1.1. Global Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)
  • 8.2. Liposomes and Nanoparticles Market
    • 8.2.1. Overview
    • 8.2.2. Global Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
  • 8.3. Solution
    • 8.3.1. Overview
    • 8.3.2. Global Solution Market Revenue and Forecasts to 2028 (US$ Million)
  • 8.4. Emulsion
    • 8.4.1. Overview
    • 8.4.2. Global Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
  • 8.5. Suspension
    • 8.5.1. Overview
    • 8.5.2. Global Suspension Market Revenue and Forecasts to 2028 (US$ Million)
  • 8.6. Ointment
    • 8.6.1. Overview
    • 8.6.2. Global Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. Ocular Drug Delivery Market Analysis - By Disease Type

  • 9.1. Overview
  • 9.2. Global Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)
  • 9.3. Cataract
    • 9.3.1. Overview
    • 9.3.2. Cataract Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4. Dry Eye Syndrome
    • 9.4.1. Overview
    • 9.4.2. Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.5. Macular Degeneration
    • 9.5.1. Overview
    • 9.5.2. Macular Degeneration Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.6. Glaucoma
    • 9.6.1. Overview
    • 9.6.2. Glaucoma Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.7. Diabetic Retinopathy
    • 9.7.1. Overview
    • 9.7.2. Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.8. Diabetic Macular Edema
    • 9.8.1. Overview
    • 9.8.2. Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.9. Others
    • 9.9.1. Overview
    • 9.9.2. Others Market Revenue and Forecast to 2028 (US$ Mn)

10. Ocular Drug Delivery Market Analysis - By End User

  • 10.1. Overview
  • 10.2. Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)
  • 10.3. Hospitals
    • 10.3.1. Overview
    • 10.3.2. Hospitals: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Million)
  • 10.4. Ophthalmic Clinics
    • 10.4.1. Overview
    • 10.4.2. Ophthalmic Clinics: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Million)
  • 10.5. Ambulatory Surgical Centers
    • 10.5.1. Overview
    • 10.5.2. Ambulatory Surgical Centers: Ocular Drug Delivery Market- Revenue and Forecast to 2028 (US$ Million)

11. Global Ocular Drug Delivery Market - Geographic Analysis

  • 11.1. North America: Ocular Drug Delivery Market
    • 11.1.1. Overview
    • 11.1.2. North America: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
    • 11.1.3. North America Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    • 11.1.4. North America Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
    • 11.1.5. North America Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
    • 11.1.6. North America Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
    • 11.1.7. North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
      • 11.1.7.1. US: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.1.1. US: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.1.2. US Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.1.3. US: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.1.4. US: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.1.5. US: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.7.2. Canada: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.2.1. Canada: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.2.2. Canada Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.2.3. Canada Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.2.4. Canada Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.2.5. Canada Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.7.3. Mexico: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.3.1. Mexico: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.3.2. Mexico Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.3.3. Mexico Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.3.4. Mexico Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.3.5. Mexico Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • 11.2. Europe: Ocular Drug Delivery Market Revenue and Forecasts to 2028
    • 11.2.1. Overview
    • 11.2.2. Europe: Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
    • 11.2.3. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
    • 11.2.4. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
    • 11.2.5. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
    • 11.2.6. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
    • 11.2.7. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)
      • 11.2.7.1. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.1.1. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.1.2. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.2.7.1.3. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
        • 11.2.7.1.4. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
        • 11.2.7.1.5. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
      • 11.2.7.2. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.2.1. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.2.2. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.2.7.2.3. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
        • 11.2.7.2.4. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
        • 11.2.7.2.5. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
      • 11.2.7.3. France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.3.1. France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.3.2. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.2.7.3.3. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
        • 11.2.7.3.4. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
        • 11.2.7.3.5. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
      • 11.2.7.4. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.4.1. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.4.2. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.2.7.4.3. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
        • 11.2.7.4.4. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
        • 11.2.7.4.5. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
      • 11.2.7.5. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.5.1. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.5.2. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.2.7.5.3. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
        • 11.2.7.5.4. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
        • 11.2.7.5.5. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
      • 11.2.7.6. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.6.1. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Mn)
        • 11.2.7.6.2. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
        • 11.2.7.6.3. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Mn)
        • 11.2.7.6.4. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Mn)
        • 11.2.7.6.5. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Mn)
  • 11.3. Asia Pacific: Ocular Drug Delivery Market
    • 11.3.1. Overview
    • 11.3.2. Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
    • 11.3.3. Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
    • 11.3.4. Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
    • 11.3.5. Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
    • 11.3.6. Asia Pacific: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
    • 11.3.7. Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
      • 11.3.7.1. China: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.1.1. China: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.1.2. China: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
        • 11.3.7.1.3. China: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
        • 11.3.7.1.4. China: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
        • 11.3.7.1.5. China: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
      • 11.3.7.2. Japan: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.2.1. Japan: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.2.2. Japan: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
        • 11.3.7.2.3. Japan: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
        • 11.3.7.2.4. Japan: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
        • 11.3.7.2.5. Japan: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
      • 11.3.7.3. India: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.3.1. India: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.3.2. India: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
        • 11.3.7.3.3. India: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
        • 11.3.7.3.4. India: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
        • 11.3.7.3.5. India: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
      • 11.3.7.4. Australia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.4.1. Australia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.4.2. Australia: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
        • 11.3.7.4.3. Australia: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
        • 11.3.7.4.4. Australia: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
        • 11.3.7.4.5. Australia: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
      • 11.3.7.5. South Korea: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.5.1. South Korea: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.5.2. South Korea: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
        • 11.3.7.5.3. South Korea: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
        • 11.3.7.5.4. South Korea: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
        • 11.3.7.5.5. South Korea: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
      • 11.3.7.6. Rest of Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.6.1. Rest of Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.6.2. Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019-2028 (USD Million)
        • 11.3.7.6.3. Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019-2028 (USD Million)
        • 11.3.7.6.4. Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019-2028 (USD Million)
        • 11.3.7.6.5. Rest of Asia Pacific: Ocular Drug Delivery Market, by End User, 2019-2028 (USD Million)
  • 11.4. Middle East and Africa: Ocular Drug Delivery Market
    • 11.4.1. Overview
    • 11.4.2. Middle East & Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.3. Middle East and Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.4. Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.5. Middle East and Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.6. Middle East and Africa: Ocular Drug Delivery Market, by End Users - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.7. Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
      • 11.4.7.1. Saudi Arabia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.1. Saudi Arabia: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.2. Saudi Arabia: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.3. Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.4. Saudi Arabia: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.5. Saudi Arabia: Ocular Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 11.4.7.2. UAE: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.1. UAE: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.2. UAE: Ocular Drug Delivery Market , by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.3. UAE: Ocular Drug Delivery Market , by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.4. UAE: Ocular Drug Delivery Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.5. UAE: Ocular Drug Delivery Market , by End User - Revenue and Forecast to 2028 (US$ Million)
      • 11.4.7.3. South Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.1. South Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.2. South Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.3. South Africa: Ocular Drug Delivery Market , by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.4. South Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.5. South Africa: Ocular Drug Delivery Market, by End user-Revenue and Forecast to 2028 (US$ Million)
      • 11.4.7.4. Rest of Middle East and Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.1. Rest of Middle East and Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.2. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.3. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.4. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.5. Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User- Revenue and Forecast to 2028 (US$ Million)
  • 11.5. South and Central America: Ocular Drug Delivery Market
    • 11.5.1. South and Central America: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
    • 11.5.2. South and Central America Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
    • 11.5.3. South and Central America Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
    • 11.5.4. South and Central America Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
    • 11.5.5. South and Central America Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)
    • 11.5.6. South and Central America: Ocular Drug Delivery Market Share by Country - 2021 & 2028, (%)
      • 11.5.6.1. Brazil: Ocular Drug Delivery Market- Revenue and Forecasts To 2028 (USD Million)
        • 11.5.6.1.1. Brazil: Ocular Drug Delivery Market- Revenue and Forecasts To 2028 (USD Million)
        • 11.5.6.1.2. Brazil Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.1.3. Brazil Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.1.4. Brazil Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.1.5. Brazil Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)
      • 11.5.6.2. Argentina: Ocular Drug Delivery Market- Revenue and Forecasts To 2028 (USD Million)
        • 11.5.6.2.1. Argentina: Ocular Drug Delivery Market- Revenue and Forecasts To 2028 (USD Million)
        • 11.5.6.2.2. Argentina Ocular Drug Delivery Market, By Technology - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.2.3. Argentina Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.2.4. Argentina Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.2.5. Argentina Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)
      • 11.5.6.3. Rest of South and Central America: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.3.1. Rest of South and Central America: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.3.2. Rest of South and Central America Ocular Drug Delivery Market, - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.3.3. Rest of South and Central America Ocular Drug Delivery Market, By Formulation Type - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.3.4. Rest of South and Central America Ocular Drug Delivery Market, By Disease Type - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.3.5. Rest of South and Central America Ocular Drug Delivery Market, By End User - Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Ocular Drug Delivery Market

  • 12.1. North America: Impact Assessment of COVID-19 Pandemic
  • 12.2. Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3. Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4. Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 12.5. South and Central America: Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

  • 13.1. Overview
  • 13.2. Growth Strategies Done by the Companies in the Market, (%)
  • 13.3. Organic Developments
    • 13.3.1. Overview
  • 13.4. Inorganic Developments
    • 13.4.1. Overview

14. Company Profiles

  • 14.1. AbbVie Inc.
    • 14.1.1. Key Facts
    • 14.1.2. Business Description
    • 14.1.3. Products and Services
    • 14.1.4. Financial Overview
    • 14.1.5. SWOT Analysis
    • 14.1.6. Key Developments
  • 14.2. Bausch Health Companies Inc.
    • 14.2.1. Key Facts
    • 14.2.2. Business Description
    • 14.2.3. Products and Services
    • 14.2.4. Financial Overview
    • 14.2.5. SWOT Analysis
    • 14.2.6. Key Developments
  • 14.3. Taiwan Liposome Company, Ltd.
    • 14.3.1. Key Facts
    • 14.3.2. Business Description
    • 14.3.3. Products and Services
    • 14.3.4. Financial Overview
    • 14.3.5. SWOT Analysis
    • 14.3.6. Key Developments
  • 14.4. Ocular Therapeutix, Inc.
    • 14.4.1. Key Facts
    • 14.4.2. Business Description
    • 14.4.3. Products and Services
    • 14.4.4. Financial Overview
    • 14.4.5. SWOT Analysis
    • 14.4.6. Key Developments
  • 14.5. GRAYBUG VISION, INC.
    • 14.5.1. Key Facts
    • 14.5.2. Business Description
    • 14.5.3. Products and Services
    • 14.5.4. Financial Overview
    • 14.5.5. SWOT Analysis
    • 14.5.6. Key Developments
  • 14.6. Alimera Sciences, Inc.
    • 14.6.1. Key Facts
    • 14.6.2. Business Description
    • 14.6.3. Products and Services
    • 14.6.4. Financial Overview
    • 14.6.5. SWOT Analysis
    • 14.6.6. Key Developments
  • 14.7. Envisia Therapeutics
    • 14.7.1. Key Facts
    • 14.7.2. Business Description
    • 14.7.3. Products and Services
    • 14.7.4. Financial Overview
    • 14.7.5. SWOT Analysis
    • 14.7.6. Key Developments
  • 14.8. Novartis AG
    • 14.8.1. Key Facts
    • 14.8.2. Business Description
    • 14.8.3. Products and Services
    • 14.8.4. Financial Overview
    • 14.8.5. SWOT Analysis
    • 14.8.6. Key Developments
  • 14.9. EYEGATE PHARMACEUTICALS, INC
    • 14.9.1. Key Facts
    • 14.9.2. Business Description
    • 14.9.3. Products and Services
    • 14.9.4. Financial Overview
    • 14.9.5. SWOT Analysis
    • 14.9.6. Key Developments
  • 14.10. Clearside Biomedical, Inc
    • 14.10.1. Key Facts
    • 14.10.2. Business Description
    • 14.10.3. Products and Services
    • 14.10.4. Financial Overview
    • 14.10.5. SWOT Analysis
    • 14.10.6. Key Developments

15. Appendix

  • 15.1. About The Insight Partners
  • 15.2. Glossary of Terms